title: FGF10 inhibits dominant follicle growth and estradiol secretion in vivo in cattle.
abstract: Fibroblast growth factors (FGFs) are involved in paracrine control of follicle development. It was previously demonstrated that FGF10 decreases estradiol (E(2)) secretion in granulosa cell culture and that theca cell FGF10 mRNA expression is decreased in healthy follicles from abattoir ovaries. The main objectives of this study were to evaluate FGF10 and FGFR2b mRNA expression during follicular development in vivo, to evaluate the effect of FGF10 on follicle growth using Bos taurus taurus cows as a model, and to gain more insight into the mechanisms through which FGF10 inhibits steroidogenesis. Messenger RNA encoding both FGF10 and FGFR2b (main FGF10 receptor) was significantly more expressed in subordinate follicles (SFs) than in dominant follicles (DFs). The intrafollicular injection of FGF10 into the largest growing follicle at 7-8 mm in diameter interrupted the DF growth in a dose-dependent manner (11±0.4, 8.3±1 and 5.9±0.3 mm for 0, 0.1, and 1 μg/ml FGF10, respectively, at 72 h after treatment; P<0.05). In a third experiment, follicles were obtained 24 h after FGF10 (1 μg/ml) or PBS treatment through ovariectomy. In theca cells, FGF10 treatment did not affect mRNA encoding steroidogenic enzymes, LHCGR and IGFBPs, but significantly upregulated FGF10 mRNA expression. The expression of CYP19A1 mRNA in granulosa cells was downregulated by FGF10 treatment, which was accompanied by a 50-fold decrease in E(2) production, and decreased cyclin D2 mRNA. These results have shown that FGF10 and its receptor FGFR2b are more expressed in SFs and provide solid in vivo evidence that FGF10 acts as an important regulator of follicular growth in cattle.
authors.affiliation: Laboratory of Biotechnology and Animal Reproduction, BioRep, Federal University of Santa Maria, Santa Maria, Rio Grande do Sul, Brazil.
authors.forename: Bernardo G
authors.initials: BG
authors.lastname: Gasperin
authors.forename: Rogério
authors.initials: R
authors.lastname: Ferreira
authors.forename: Monique T
authors.initials: MT
authors.lastname: Rovani
authors.forename: Joabel T
authors.initials: JT
authors.lastname: Santos
authors.forename: José
authors.initials: J
authors.lastname: Buratini
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Price
authors.forename: Paulo Bayard D
authors.initials: PB
authors.lastname: Gonçalves
mesh_terms: D000818:Animals; D002417:Cattle / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D015536:Down-Regulation / Q000187:drug effects; D004958:Estradiol / Q000378:metabolism*; D005260:Female; D051526:Fibroblast Growth Factor 10 / Q000008:administration & dosage / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology*; D015870:Gene Expression / Q000187:drug effects; D006107:Granulosa Cells / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D008845:Microinjections; D009866:Oogenesis / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D006080:Ovarian Follicle / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism / Q000502:physiology; D051497:Receptor, Fibroblast Growth Factor, Type 2 / Q000235:genetics / Q000378:metabolism; D013799:Theca Cells / Q000187:drug effects / Q000378:metabolism / Q000502:physiology
chemical_list: D051526:Fibroblast Growth Factor 10; D004958:Estradiol; D051497:Receptor, Fibroblast Growth Factor, Type 2